Science & Tech Lab
BEAT · 44 EXPERIMENTS

Biotech.

Genomics, medicine & life sciences

Latest Biotech stories

Lab-grown mini-organs reveal how COVID targets the brain
Biotech

Lab-grown mini-organs reveal how COVID targets the brain

Biotech desk — Lab-grown mini-organs reveal how COVID targets the brain. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 30, 1969·8m read
CRISPR therapy restores hearing in 16 children born deaf
Biotech

CRISPR therapy restores hearing in 16 children born deaf

Biotech desk — CRISPR therapy restores hearing in 16 children born deaf. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 30, 1969·9m read
Scientists sequence a mammoth genome from 19,000-year-old fossils
Biotech

Scientists sequence a mammoth genome from 19,000-year-old fossils

Biotech desk — Scientists sequence a mammoth genome from 19,000-year-old fossils. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 27, 1969·7m read
Lab-grown mini-organs reveal how COVID targets the brain
Biotech

Lab-grown mini-organs reveal how COVID targets the brain

Biotech desk — Lab-grown mini-organs reveal how COVID targets the brain. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 20, 1969·6m read
CRISPR therapy restores hearing in 82 children born deaf
Biotech

CRISPR therapy restores hearing in 82 children born deaf

Biotech desk — CRISPR therapy restores hearing in 82 children born deaf. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 16, 1969·8m read
New antibiotic class defeats resistant gonorrhea strains
Biotech

New antibiotic class defeats resistant gonorrhea strains

Biotech desk — New antibiotic class defeats resistant gonorrhea strains. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 16, 1969·3m read
Ozempic-style drug shows brain-protective effects in Alzheimer's
Biotech

Ozempic-style drug shows brain-protective effects in Alzheimer's

Biotech desk — Ozempic-style drug shows brain-protective effects in Alzheimer's. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 14, 1969·3m read
Base editors correct sickle-cell mutation in early trials
Biotech

Base editors correct sickle-cell mutation in early trials

Biotech desk — Base editors correct sickle-cell mutation in early trials. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 12, 1969·7m read
New antibiotic class defeats resistant gonorrhea strains
Biotech

New antibiotic class defeats resistant gonorrhea strains

Biotech desk — New antibiotic class defeats resistant gonorrhea strains. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 8, 1969·8m read
Cancer vaccine trial cuts recurrence by 89% in melanoma patients
Biotech

Cancer vaccine trial cuts recurrence by 89% in melanoma patients

Biotech desk — Cancer vaccine trial cuts recurrence by 89% in melanoma patients. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Dec 2, 1969·6m read
Cancer vaccine trial cuts recurrence by 71% in melanoma patients
Biotech

Cancer vaccine trial cuts recurrence by 71% in melanoma patients

Biotech desk — Cancer vaccine trial cuts recurrence by 71% in melanoma patients. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Nov 16, 1969·3m read
Synthetic embryo model develops beating heart in the lab
Biotech

Synthetic embryo model develops beating heart in the lab

Biotech desk — Synthetic embryo model develops beating heart in the lab. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Nov 15, 1969·4m read
First pig-kidney transplant recipient reaches 49-month milestone
Biotech

First pig-kidney transplant recipient reaches 49-month milestone

Biotech desk — First pig-kidney transplant recipient reaches 49-month milestone. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Nov 14, 1969·3m read
Ozempic-style drug shows brain-protective effects in Alzheimer's
Biotech

Ozempic-style drug shows brain-protective effects in Alzheimer's

Biotech desk — Ozempic-style drug shows brain-protective effects in Alzheimer's. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Nov 12, 1969·10m read
Base editors correct sickle-cell mutation in early trials
Biotech

Base editors correct sickle-cell mutation in early trials

Biotech desk — Base editors correct sickle-cell mutation in early trials. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Oct 25, 1969·6m read
Xenobots reproduce in a way never seen in biology
Biotech

Xenobots reproduce in a way never seen in biology

Biotech desk — Xenobots reproduce in a way never seen in biology. Early analysis suggests broader implications for researchers, industry and policymakers tracking the field.

Jamal ANIBA·Oct 25, 1969·6m read
PAGE 01 / 03